# Regulation on medical examinations of employees (lead – § 13a)

Regulation of the Minister of Health and Social Welfare of 30 May 1996 on medical examinations of employees, the scope of preventive health care for employees and medical certificates issued for the purposes provided for in the Labour Code (rozporządzenie w sprawie przeprowadzania badań lekarskich pracowników, zakresu profilaktycznej opieki zdrowotnej nad pracownikami oraz orzeczeń lekarskich wydawanych do celów przewidzianych w Kodeksie pracy)

- Status: In force
- Legal order: Poland
- Legal area: Chemicals and worker health
- Dz.U. 2023 poz. 607 (consolidated text), as amended (Dz.U. 2026 poz. 456 and 726)
- Business profile: Smelting, Semi-fabrication, Recycling

## In brief

Sets the thresholds for preventive examinations in the case of exposure to lead in line with Directive 2024/869, and a transitional provision for workers with elevated PbB before 9.04.2026.

## Key obligations

- preventive examinations where lead in air is >0.015 mg/m³ (TWA 40 h) or PbB >9 µg/100 ml (§ 13a(3))
- preventive examinations of female workers of childbearing age with PbB >4.5 µg/100 ml (§ 13a(4))
- until 31.12.2028 PbB of 30–70 µg/100 ml resulting from exposure before 9.04.2026: regular examinations; work permitted where there is a downward trend (§ 2(2) Dz.U. 2026 poz. 726)
- from 1.01.2029 PbB of 15–30 µg/100 ml resulting from exposure before 9.04.2026: regular examinations; work permitted where there is a downward trend (§ 13a(1)–(2))

## Competent authority

Physician providing preventive health care; National Labour Inspectorate

## Penalties

Art. 283 § 1 of the Labour Code – fine of PLN 2,000 to 60,000

## Entry into force

26.07.1996

## Application

§ 13a from 4.06.2026; value of 15 µg/100 ml from 1.01.2029

## Key dates

- 17.04.2026: Dz.U. 2026 poz. 456 enters into force – inter alia individual recommendations, certificates in electronic form
- 04.06.2026: Dz.U. 2026 poz. 726 enters into force – § 13a (lead)
- 01.01.2029: PbB limit value 15 µg/100 ml (§ 13a(1))

## Related acts

- [Regulation of the Minister of Health – OHS and chemical agents (PbB 30/15)](https://igmnir.org/dane/prawo/en/pl-bhp-czynniki-chemiczne/)
- [Directive 2024/869 – lead (OEL, BLV) and diisocyanates](https://igmnir.org/dane/prawo/en/eu-cmrd-2024-869/)

## Official sources

- [Text of the act](https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU19960690332)
- [Consolidated text](https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20230000607)
- [Journal of Laws – Dz.U. 2026 poz. 726](https://dziennikustaw.gov.pl/DU/2026/726)
- [Journal of Laws – Dz.U. 2026 poz. 456](https://dziennikustaw.gov.pl/DU/2026/456)

---

Register as of: 22.10.2026. The official text of the act prevails. IGMNiR. On the website: https://igmnir.org/en/law/#akt-pl-badania-lekarskie